Altered redox regulation and S-glutathionylation of BiP contribute to bortezomib resistance in multiple myeloma.
Multiple myeloma (MM) cells have high rates of secretion of proteins rich in disulfide bonds and depend upon compartmentalized redox balance for accurate protein folding. The proteasome inhibitor bortezomib (Btz) is a successful frontline treatment for the disease, but its long-term efficacy is restricted by the acquisition of resistance. We found that MM cell lines resistant to Btz maintain high levels of oxidative stress and are cross resistant to endoplasmic reticulum (ER) stress-inducing agents thapsigargin (ThG), and tunicamycin (TuM). Moreover, cells expressing high/wild type levels of glutathione S-transferase P (GSTP) are more resistant than Gstp1/p2 knockout cells. In agreement, basal levels of S-glutathionylated proteins and redox regulation enzymes, including GSTP are elevated at mRNA and protein levels in resistant cells. GSTP mediated S-glutathionylation (SSG) regulates the activities of a number of redox active ER proteins. Here we demonstrated that the post-translational modification determines the balance between foldase and ATPase activities of the binding immunoglobulin protein (BiP), with Cys41-SSG important for ATPase, and Cys420-SSG for foldase. BiP expression and S-glutathionylation are increased in clinical specimens of bone marrow from MM patients compared to non-cancerous samples. Preventing S-glutathionylation in MM cells with a GSTP specific inhibitor restored BiP activities and reversed resistance to Btz. Therefore, S-glutathionylation of BiP confers pro-survival advantages and represents a novel mechanism of drug resistance in MM cells. We conclude that altered GSTP expression leads to S-glutathionylation of BiP, and contributes to acquired resistance to Btz in MM.
['Zhang|Jie|J|', 'Ye|Zhi-Wei|ZW|', 'Chen|Wei|W|', 'Culpepper|John|J|', 'Jiang|Haiming|H|', 'Ball|Lauren E|LE|', 'Mehrotra|Shikhar|S|', 'Blumental-Perry|Anna|A|', 'Tew|Kenneth D|KD|', 'Townsend|Danyelle M|DM|']
D000069286:Bortezomib D002352:Carrier Proteins D019008:Drug Resistance, Neoplasm D005978:Glutathione D006801:Humans D007136:Immunoglobulins D009101:Multiple Myeloma D010084:Oxidation-Reduction
Redox S-glutathionylation BiP Bortezomib Multiple myeloma Endoplasmic reticulum Glutathione Glutathione S-Transferase Reactive oxygen species Unfolded protein response